Technological excellence

Slides:

Advertisements

Similar presentations

Sri Lanka Summit Durham University Enterprise & Engagement Case Studies Presented by John Hirst 5 th March, 2010.

Advertisements

Local Public Health System Assessment

¨ Dr Alain Garcia General Secretary of the Rare Diseases National Plan The second National Plan for Rare Diseases in France

Biomedical Engineering Initiative: Creating the next generation of healthcare innovators in Africa Muhammad H. Zaman Director, LEED, Boston University.

Delivering Innovative Solutions to Real-World Problems, Through Transdisciplinary Research Delivering Innovative Solutions to Real-World Problems, Through.

Empowering Food and Agricultural Research through New Initiatives John E. Courtney, Ph.D. Executive Officer American Society for Nutrition.

POZNAŃ SUPERCOMPUTING AND NETWORKING CENTER Center of e-Infrastructure Center of e-Infrastructure Center for R+D in ICT and their applications POZMAN.

Driving Innovation Concept to Commercialisation A strategy for business innovation, Zahid Latif Head of Healthcare Mark Glover 12 th January.

1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.

Funding for Innovation Sue Dunkerton, HealthTech and Medicines KTN 11 December 2012.

Cancer Nanotechnology: New Opportunities for Targeted Therapies FDA Public Meeting October 10, 2006 Piotr Grodzinski, Ph.D. Director, Nanotechnology for.

1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical development Phase I Phase II Phase III Product.

1 Presentation title - edit in the Master slide 1 Current Investment Opportunities Professor Rory Shaw, Medical Director, Healthcare UK, UKTI.

The South African Malaria Initiative A Case Study E Jane Morris Bridging the Gap in Global Health Innovation - from Needs to.

Kick-off University Partners Meeting September 18, 2012 Michael Owen, VP Research, Innovation & International, UOIT on behalf of Consortium partners Southern.

Florida Center of Excellence for Biomolecular Identification and Targeted Therapeutics.

FORESIGHT STUDY Future Trends and Challenges in Pathogenomics JUDITH SIMON & SVEN POMPE PROGRAMME GROUP MUT.

European Health Forum Gastein, Bad Hofgastein, Austria, September 2002 Towards the Sixth Framework Programme Parallel Forum V 26 September 2002 Public.

Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.

Horizon 2020 The EU Framework Programme for Research and Innovation Health, Demographic Change and Wellbeing Lul Raka, NCP for Horizon 2020 – Health.

Bioinformatics Education: Training a New Generation of Professionals Patricia Dombrowski May 2005.

T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.

Overview & Industry Partnership Opportunities ©2012 Larta Institute

Partnering with Federal Labs: A Panel Discussion FLC Mid-Atlantic Region Annual Meeting October 24, 2007.

Public Private collaborations to optimise translational research and pathways to patients: IMI Magda Chlebus, Director Science Policy Warsaw, 22 May 2015.

Where to focus? Horizon 2020 'Health, demographic change and wellbeing' Open Info Day -Horizon 2020 'Health, demographic change and wellbeing' Brussels,

Polish Technology Platform for Biotechnology Partnering Meeting in Birini, Presented by Zygmunt Krasiński National Contact Point for Research.

Raising Personal Inclination and Usability of ICT supported Health Roman Trobec 1, Viktor Avbelj 1 and Uroš Stanič 2 1 Jožef Stefan Institute, Jamova 39,

Science and Technology Business Incentive Programs New Jersey Commission on Science and Technology Peter R. Reczek, Ph. D. Executive Director.

1. 2 Who We Are – North Texas RCIC Connecting Innovation & Capital Our mission... to accelerate the growth of the North Texas technology based economy.

Our Mission: To acquire and administer funds to support and sustain the advancement of healthcare knowledge and discovery for the benefit of America’s.

Changing Views External Influences for Healthcare Dr R Hangartner.

The innovation that telemedicine promises is not just doing the same thing remotely that used to be done face to face but awakening us to the many things.

Knowledge Transfer Accelerating Innovation. slide 1 The Knowledge Transfer Group at the HR Induction Program (session II) 6 th September 2011 Enrico Chesta.

NHS Confederation Annual Conference 4 June Matching Health with Growth – the UHB Story.

Horizon 2020 Overview Jerome de Barros NCP Health.

National Information Day Greece 23 July 2015 Funding priorities under the work plan 2015.

Systemic change by streamlined innovation: personalised medicine Novembre 8, 2013.

1 Extending the Wisconsin Idea UW Funding Opportunities for Technologies with Promising Potential.

Research Speed Updating: Health and wellbeing 9 July 2014.

BioMedical Cluster New opportunities for innovators and investors with Bio-Medical Cluster of Skolkovo Foundation Innovation in Medical Technologies Conference,

The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.

Professor Orla Hardiman HRB Clinician Scientist Innovation Its role in Delivering Better Health Outcomes.

Knowledge Transfer Accelerating Innovation. slide 1 The Knowledge Transfer Group at the HR Induction Program (session II) 9 th June 2011 Giovanni Anelli.

Technological excellence

NIHR Invention for Innovation (i4i)

WHO’s prioritised research agenda for the prevention and control of NCDs prioritises

The guiding principles of prudent healthcare

FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health

UNITAID Overview Joint Consultation on Seasonal Malaria Chemoprevention Ouagadougou, Burkina Faso, February 2017.

The International Cancer Expert Corps (ICEC) mentorship model for sustainable cancer care in Low- and Middle Income Countries (LMIC) and indigenous populations.

Dementia Research and Enterprise at Liverpool John Moores University

Gestora brasileiro focada exclusivamente na área da saúde.

applications Agriculture

A Centre for New Methods in Computational Diagnostics and Personalised Therapy This EU H2020 ‘Teaming for Excellence’ project develops a Business Case.

Technology park Ljubljana

Finland, a Global Testbed for Personalized Cancer Research?

The Industrial Strategy Challenge Fund & the Focus on Life Sciences

Medical biotechnology is our topic.

EXPLORING GLOBAL COOPERATION OPPORTUNITIES

Antibiotic Resistance: Strategic Solutions

Dementia United Greater Manchester’s (GM’s) dementia strategy

NICON Conference Driving Innovation: WHSCT approach

Artificial Intelligence in the Health Sector

Innovation in Healthcare across the EU WhiteRoseBrussels

H2020 Infoday on Photonics Topics

FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health

Dementia United Greater Manchester’s (GM’s) dementia strategy

Dr Manisha Shridhar Regional Advisor WHO-SEARO

STRATEGIC ACTION IN HEALTH (AES)

Presentation transcript:

Technological excellence SRIP Health- medicine Progressive medicine Technological excellence Improved healthcare Contact: dr. Alenka Rožaj Brvar, MBA, director direktor@sis-egiz.eu http://www.sis-egiz.eu/en/ The Operation is funded by Republic of Slovenia and European Union from European Fund for Regional Development.

Slovenian National Innovation Hub and SRIP Health - Medicine Public - private partnership of the leading national partners from multiple helix, employing cutting edge technologies enabling access to global medical and health markets. A PLATFORM FOR: knowledge transfer from academia, R&D, business and NGO organizations; fostering innovation & IP, global networking, communication to Government; identification of new business opportunities, promising technologies, large scale projects; new technological and social innovative solutions, top talent development, new jobs, high VA products and services, start-ups, best practice sharing. Technical implementation Development Validation Certification Evaluation Marketing

In focus SRIP - Health - Medicine Translational medicine Biopharmaceutics Herbal medicine and natural cosmetics Resistant bacteria Cancer treatment Active and Healthy Aging Central nervous systems diseases Regenerative medicine Advanced medicine and new delivery systems Digestive syndrome Rare diseases Biopharmaceutical production Novel biological medicines and vaccines Herbal Medicine Dietary supplements Natural Cosmetics New forms of disinfectants Plant extracts Antibacterial materials Proton therapy Cell therapy Gene therapy Diagnostics, Neurotoxic/ Neurodegeneration, New products and services for Active Healthy Aging In focus SRIP - Health - Medicine Active Healthy Aging: smart medical devices for assisted living, including telemedicine and autotherapeutic devices; Diagnostics: early diagnosis of dementia, AD (bio-nanosensors); Therapeutics: new drug delivery nanoparticle systems, stem cells; Support environment: wearables, training of staff in nursery homes, educating relatives, memory villages.